Lack of initiating activity of kojic acid on hepatocarcinogenesis in F344 rats

Journal of Toxicologic Pathology

Volumn 18, Issue 2, 2005, Pages 79-84

  Watanabe, Takao ^a   Mori, Taeko ^a   Kitamura, Yasuki ^b   Umemura, Takashi ^b   Okamura, Miwa ^a   Kashida, Yoko ^a   Nishikawa, Akiyoshi ^b   Hirose, Masao ^b   Mitsumori, Kunitoshi ^a  

^a TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^b NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

F344 rat; Hepatocarcinogenicity; Kojic acid; Liver initiation assay

Indexed keywords

EID: 27444441658     PISSN: 09149198     EISSN: None     Source Type: Journal    
DOI: 10.1293/tox.18.79     Document Type: Article

References (32)

1. Parrish FW, Wiley BJ, Simmons EG, and Long L Jr. Production of aflatoxins and kojic acid by species of Aspergillus and Penicillium. Appl Microbiol. 14: 139. 1966.
2. Kwak MY and Rhee JS. Cultivation characteristics of immobilized Aspergillus oryzae for kojic acid production. Biotechnol Bioeng. 39: 903-906. 1992.
3. Saruno R, Kato F, and Ikeno T. Kojic acid, a tyrosinase inhibitor from Aspergillus albus. Agric Biol Chem. 43: 1337-1339. 1979.
4. Chen JS, Wei CI, Rolle RS, Otwell WS, Balaban MO, and Marshall MR. Inhibitory effect of kojic acid on some plant and crustacean polyphenol oxidase. J Agric Food Chem. 39: 1396-1401. 1991.
5. Kahn V. Effect of kojic acid on the oxidation of DL-DOPA, norepinephrine and dopamine by mushroom tyrosinase. Pigment Cell Res. 8: 234-240. 1995.
6. Ohyama Y. Melanogenesis-inhibitory effect of kojic acid and its action mechanism. Fragrance J. 6: 53-58. 1990.
7. Perez-Bernal A, Munoz-Perez MA, and Camacho F. Management of facial hyperpigmentation. Am J Clin Dermatol. 1: 261-268. 2000.
8. Maeda K and Fukuda M. In vitro effectiveness of several whitening cosmetic components in human melanocytes. J Soc Cosmet Chem. 42: 361-368. 1991.
9. Fujimoto N, Watanabe H, Nakatani T, Roy G, and Ito A. Induction of thyroid tumors in (C57BL/6N×C3H/N)F1 mice by oral administration of kojic acid. Food Chem Toxicol. 36: 697-703. 1998.
10. Takizawa T, Mitsumori K, Tamura T, Nasu M, Ueda M, Imai T, and Hirose M. Hepatocellular tumor induction in heterozygous p53-deficient CBA mice by a 26-week dietary administration of kojic acid. Toxicol Sci. 73: 287-293. 2003.
11. Mitsumori K, Onodera H, Shimo T, Yasuhara K, Takagi H, Koujitani T, Hirose M, Maruyama C, and Wakana S. Rapid induction of uterine tumors with p53 point mutations in heterozygous p53-deficient CBA mice given a single intraperitoneal administration of N-ethyl-N-nitrosourea. Carcinogenesis. 21: 1039-1042. 2000.
12. Onodera H, Mitsumori K, Takagi H, Yasuhara K, Koujitani T, Tamura T, and Hirose M. Susceptibility of heterozygous p53 deficient CBA mice to induction of liver proliferative lesions by phenobarbital after dimethylnitrosamine initiation. J Toxicol Pathol. 14: 273-278. 2001.
13. Takizawa T, Mitsumori K, Takagi H, Onodera H, Yasuhara K, Tamura T, and Hirose M. Modifying effects of flumequine on dimethylnitrosamine-induced hepatocarcinogenesis in heterozygous p53 deficient CBA mice. J Toxicol Pathol. 14: 135-143. 2001.
14. Takizawa T, Imai T, Onose J, Ueda M, Tamura T, Mitsumori K, Izumi K, and Hirose M. Enhancement of hepatocarcinogenesis by kojic acid in rat two-stage models after initiation with N-bis(2-hydroxypropyl)nitrosamine or N-diethylnitrosamine. Toxicol Sci. 81: 43-49. 2004.
15. Shibuya T, Murata T, Sakamoto K, Iwahara S, and Ikeno M. Mutagenicity and dominant lethal test of kojic acid. Toxicol Sci. 7: 255-262. 1982.
16. Wei CI, Huang TS, Fernando SY, and Chung KT. Mutagenicity studies of kojic acid. Toxicol Lett. 59: 213-220. 1991.
17. Kinoshita R, Ishino T, Sugiyama S, Seto T, Igarashi S, and Goetz IE. Mycotoxins in fermented food. Cancer Res. 28: 2296-2311. 1968.
18. Stark AA. Mutagenicity and carcinogenicity of mycotoxins: DNA binding as a possible mode of action. Annu Rev Microbiol. 34: 235-262. 1980.
19. Tsuda H, Lee G, and Farber E. Induction of resistant hepatocytes as a new principle for a possible short-term in vivo test for carcinogens. Cancer Res. 40: 1157-1164. 1980.
20. Sakai H, Tsukamoto T, Yamamoto M, Yanai T, Masegi T, Inada K, Nakanishi H, and Tatematsu M. Summation of initiation activities of low doses of the nonhepatocarcinogen 1,2-dimethylhydrazine in the liver after carbon tetrachloride administration. Cancer Lett. 148: 59-63. 2000.
21. Dunnett CW. A multiple comparison procedure for comparing several treatments with a control. J Am Stat Association. 50: 1096-1121. 1955.
22. Gosset WS (Student). The probable error of a mean. Biometrika. 6: 1-25. 1908.
23. Dunnick JK, Hardisty JF, Herbert RA, Seely JC, Furedi-Machacek EM, Foley JF, Lacks GD, Stasiewicz S, and French JE. Phenolphthalein induces thymic lymphomas accompanied by loss of the p53 wild type allele in heterozygous p53-deficient (+/-) mice. Toxicol Pathol. 25: 533-540. 1997.
24. Tennant RW, French JE, and Spalding JW. Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models. Environ Health Perspect. 103: 942-950. 1995.
25. Tennant RW, Spalding J, and French JE. Evaluation of transgenic mouse bioassays for identifying carcinogens and noncarcinogens. Mutat Res. 365: 119-127. 1996.
26. Ishidate MJr, Harnois MC, and Sofuni T. A comparative analysis of data on the clastogenicity of 951 chemical substances tested in mammalian cell cultures. Mutat Res. 195: 151-213. 1988.
27. Sakai H, Tsukamoto T, Yamamoto M, Kobayashi K, Yuasa H, Imai T, Yanai T, Masegi T, and Tatematsu M. Distinction of carcinogens from mutagens by induction of liver cell foci in a model for detection of initiation activity. Cancer Lett. 188: 33-38. 2002.
28. Kolaja KL, Stevenson DE, Walborg EFJr, and Klaunig JE. Dose dependence of phenobarbital promotion of preneoplastic hepatic lesions in F344 rats and B6C3F1 mice: effects on DNA synthesis and apoptosis. Carcinogenesis. 17: 947-954. 1996.
29. Shoda T, Mitsumori K, Onodera H, Toyoda K, Uneyama C, Takada K, and Hirose M. Liver tumor-promoting effect of beta-naphthoflavone, a strong CYP 1A1/2 inducer, and the relationship between CYP 1A1/2 induction and Cx32 decrease in its hepatocarcinogenesis in the rat. Toxicol Pathol. 28: 540-547. 2000.
30. WAF1/Cip1, cyclin D1 and Ogg1. Carcinogenesis. 23: 341-349. 2002.
31. Mitsumori K, Onodera H, Takahashi M, Funakoshi T, Tamura T, Yasuhara K, Takegawa K, and Takahashi M. Promoting effects of kojic acid due to serum TSH elevation resulting from reduced serum thyroid hormone levels on development of thyroid proliferative lesions in rats initiated with N-bis(2-hydroxypropyl)nitrosamine. Carcinogenesis. 20: 173-176. 1999.
32. Tamura T, Mitsumori K, Onodera H, Fujimoto N, Yasuhara K, Takegawa K, and Takahashi M. Inhibition of thyroid iodine uptake and organification in rats treated with kojic acid. Toxicol Sci. 47: 170-175. 1999.